Gregory Lynn pleads guilty to breaching intervention order, death threats against ex-wife

Amgen is using AI to design new proteins with therapeutic properties, accelerating discovery of next-generation medicines. The company's AMPLIFY protein language model co-developed with Mila teaches AI the language of proteins, making protein engineering faster, smarter and more accessible. By combining AI, automation and biology, Amgen has tripled protein engineering speed and cut discovery timelines in half. This approach, known as generative biology, replaces the traditional "search and discover" model with a "design and generate" way of thinking about biological function.